All News
Diagnostic tools in autoinflammatory syndromes
With broader awareness about the disease state, early diagnosis and treatment in autoinflammatory syndromes, and its life threatening complication Macrophage Activation Syndrome, remains a huge unmet need.
Systemic Sclerosis and Physical Therapy
Systemic sclerosis (SSc) is a chronic fibrosing disease currently with no available cure.
Read Article
Chris Wincup chriswincup ( View Tweet)
Links:
”Somatic mutation (in UBA1) may account for a significant fraction of adult-onset inflammatory disease” says Dr. Dan Kastner. Have you seen VEXAS in your clinic? #ACR20
Dr. Rachel Tate uptoTate ( View Tweet)
Dr. John Cush RheumNow ( View Tweet)
Michael Ombrello MichaelOmbrello ( View Tweet)
Olga Petryna DrPetryna ( View Tweet)
Olga Petryna DrPetryna ( View Tweet)
How often do you order LDH, AST and triglycerides in AOSD cases?
Olga Petryna DrPetryna ( View Tweet)
@RheumNow #ACR20 abs1151 screening for inflammatory hyperferritinemia may be feasible but requires additional info: inflammatory huperferritinemia more likely to correlate with ⬆️IL18, AST&thrombocytosis while high CRP+ferritin more often seen in infectious etiology https://t.co/wiFPXepxpz
How many new Adult Onset Still's Disease patients have you seen in the past year? @RheumNow #ACR20
Bella Mehta bella_mehta ( View Tweet)
European Rheum Consortium (SHARE) recommendations for Rx of systemic JIA: 1) Systemic JIA - AOSD; 2) STEROIDs, 3) IL-1 inhibitors; 4) TCZ, 5) MTX & TNFi mainly for arthritis. Should be aware of risk for MAS and ILD #ACR20 Abstr#1148 https://t.co/mgZvLKNljs
Dr. John Cush RheumNow ( View Tweet)
Bella Mehta bella_mehta ( View Tweet)
@RheumNow #acr20 abs0098 CCL2&CCR2 may play role in inflammatory response in AOSD, high levels in active AOSD subside with six resolution. Correlate with CRP, neutrophil count& ferritin levels. Does not correlate w/ Clincial markers of disease activity
Olga Petryna DrPetryna ( View Tweet)
Interim analysis of the RELIANCE registry studying effect of canakinumab (CAN) in 80 patients w/ febrile CAPS. Efficacy of CAN assessed w/ AIDA (inflam index) showing ~70% were in low activity (<9) @ACR20 Abstr#1479 https://t.co/UC2eJbpVLM https://t.co/M71s8gXZY9
Links:
Peter Nash drpnash ( View Tweet)


